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Abstract
AMPK, a master metabolic switch, mediates the observed increase of glucose uptake in locomotory muscle of mammals
during exercise. AMPK is activated by changes in the intracellular AMP:ATP ratio when ATP consumption is stimulated by
contractile activity but also by AICAR and metformin, compounds that increase glucose transport in mammalian muscle
cells. However, the possible role of AMPK in the regulation of glucose metabolism in skeletal muscle has not been
investigated in other vertebrates, including fish. In this study, we investigated the effects of AMPK activators on glucose
uptake, AMPK activity, cell surface levels of trout GLUT4 and expression of GLUT1 and GLUT4 as well as the expression of
enzymes regulating glucose disposal and PGC1a in trout myotubes derived from a primary muscle cell culture. We show
that AICAR and metformin significantly stimulated glucose uptake (1.6 and 1.3 fold, respectively) and that Compound C
completely abrogated the stimulatory effects of the AMPK activators on glucose uptake. The combination of insulin and
AMPK activators did not result in additive nor synergistic effects on glucose uptake. Moreover, exposure of trout myotubes
to AICAR and metformin resulted in an increase in AMPK activity (3.8 and 3 fold, respectively). We also provide evidence
suggesting that stimulation of glucose uptake by AMPK activators in trout myotubes may take place, at least in part, by
increasing the cell surface and mRNA levels of trout GLUT4. Finally, AICAR increased the mRNA levels of genes involved in
glucose disposal (hexokinase, 6-phosphofructokinase, pyruvate kinase and citrate synthase) and mitochondrial biogenesis
(PGC-1a) and did not affect glycogen content or glycogen synthase mRNA levels in trout myotubes. Therefore, we provide
evidence, for the first time in non-mammalian vertebrates, suggesting a potentially important role of AMPK in stimulating
glucose uptake and utilization in the skeletal muscle of fish.
Citation: Magnoni LJ, Vraskou Y, Palstra AP, Planas JV (2012) AMP-Activated Protein Kinase Plays an Important Evolutionary Conserved Role in the Regulation of
Glucose Metabolism in Fish Skeletal Muscle Cells. PLoS ONE 7(2): e31219. doi:10.1371/journal.pone.0031219
Editor: Alejandro Lucia, Universidad Europea de Madrid, Spain
Received October 26, 2011; Accepted January 4, 2012; Published February 16, 2012
Copyright:  2012 Magnoni et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grants from the Ministerio de Ciencia e Innovacion, Spain (CSD2007-0002 and AGL2009-07006) to JVP. LJM was supported
by a FP7-PIIF-2009 fellowship (Marie Curie Action) from the European Commission (GLUCOSE USE IN FISH) with grant agreement number 235581. The fundersh a d
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jplanas@ub.edu
¤ Current address: Institute for Marine Resources and Ecosystem Studies (IMARES) of the Wageningen University, Yerseke, The Netherlands
Introduction
AMP-activated protein kinase (AMPK) is a phylogenetically
conserved enzyme which has been suggested to act as a ‘metabolic
master switch’ mediating the cellular adaptation to environmental
or nutritional stress factors [1]. This fuel-sensing enzyme is
activated by phosphorylation when a cellular stress increases the
AMP:ATP ratio due to limited generation of ATP (e.g. hypoxia) or
increased ATP depletion and, consequently, AMP production (e.g.
exercise). Activation of AMPK leads to the concomitant inhibition
of energy-consuming biosynthetic pathways not required for
survival and to the activation of metabolic pathways that
regenerate the ATP, including glucose uptake and its subsequent
utilization by the tissues [2].
It is well recognized that in order to understand how energy
balance is maintained in the organism it is important to study the
mechanisms involved in the activation of AMPK in skeletal
muscle. This organ, that contributes to 40% of the resting
metabolic rate [3], undergoes an energetic challenge during
exercise-induced muscle contraction, when it shows a remarkable
increase in its ATP turnover rate [4]. Furthermore, AMPK is
activated in the skeletal muscle of mammals by exercise and this
activation is associated with an increase in glucose uptake by the
tissue [5,6]. Widespread research has been carried out studying
the activation of AMPK by synthetic compounds in the
mammalian muscle, using the adenosine analog 5-aminoimidia-
zole-4-carboxamide ribonucleoside (AICAR) and biguanide 1,1-
dimethylbiguanide hydrochloride (metformin) as pharmacologi-
cal tools (e.g. ‘‘exercise mimetics’’) to simulate the effects of
exercise on AMPK [7,8]. Given that many fish species
experience swimming-induced exercise as an integral part of
their behavior and due to the fact that in fish the contractile
skeletal muscle represents more than 50% of their body weight, it
is conceivable that AMPK could also play a key integrative role
in the physiological and metabolic adaptation to swimming in
fish skeletal muscle. AMPK activity has been measured in several
fish tissues, including skeletal muscle, and the enzyme appears to
be regulated by phosphorylation in a manner similar to
mammals [9]. More specifically, AMPK activity is up-regulated
in the liver of goldfish (Carassius auratus) after 12 h of hypoxia [9]
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goldfish brain and cardiac muscle [10]. Recently, evidence for
the pharmacological activation of AMPK has been reported for
the ability of AICAR to increase AMPK activity in goldfish
hepatocytes in vitro [11] and for both AICAR and metformin to
increase AMPK activity in rainbow trout (Oncorhynchus mykiss)
liver in vivo and in vitro [12]. However, the direct metabolic effects
of compounds that activate AMPK have never been studied in
fish muscle cells, despite the known importance of AMPK in
glucose metabolism in mammals [13] and, specifically, in
orchestrating the metabolic effects of exercise-induced contrac-
tion of locomotory muscle.
Glucose utilization is related to the ability of glucose to transfer
across the plasma membrane, a step in which glucose transporters
(GLUTs) play an essential role [14]. During the past few years,
GLUTs expressed in skeletal muscle of mammals, mostly GLUT4,
have been the focus of metabolic studies examining glucose and
energy homeostasis [15]. Exercise enhances glucose transport in
mammalian skeletal muscle by promoting the translocation of
GLUT4 to the plasma membrane [16,17] and by inducing a
transient increase in the transcription of the GLUT4 gene in this
tissue [18,19], and both mechanisms appear to be independent of
the action of insulin [20,21]. Additionally, AMPK activators such
as AICAR and metformin also increase glucose uptake in skeletal
muscle through the two mechanisms involving GLUT4
[22,23,24]. AMPK activation causes an increase in the mRNA
and protein levels of PGC-1a, a transcriptional co-factor known to
have a key role regulating the expression of several genes in the
mammalian muscle involved in energy metabolism, including
glucose disposal [25]. However, there is no information on how
AMPK activation may alter PGC-1a gene expression in fish
muscle.
In the context of the prevalent notion that teleost fish, and
particularly salmonid fish (i.e. trout and salmon), are relatively
glucose intolerant [26], we have previously shown that, like in
mammals, GLUT4 may also play a role in regulating glucose
homeostasis in salmonid fish and that GLUT4 is expressed and
regulated in skeletal muscle of rainbow trout and brown
trout (Salmo trutta) in response to insulin and feeding status
[27,28,29,30,31]. In particular, insulin stimulates the transloca-
tion of trout GLUT4 to the cell surface [29] as well as its mRNA
and protein expression in skeletal muscle both in vivo and in vitro
[28,30,31]. As in mammals, glucose uptake by peripheral tissues
in the carp (Cyprinus carpio) is increased by the administration of
glucose and metformin in vivo, improving glucose disposal [32].
Furthermore, metformin improves glucose homeostasis when
infused in vivo in trout, an effect that is associated with increased
GLUT4 expression in white muscle, suggesting a mammalian-
like effect of metformin in this species [33]. In the present study,
we have investigated the ability of AMPK activators to stimulate
endogenous AMPK activity and glucose metabolism in trout
muscle. To address this issue we have used a primary culture of
brown trout muscle cells that can reproduce the differentiation
process taking place in skeletal muscle [31] and that we have
previously used to study the direct metabolic effects of hormones
and cytokines in trout muscle [29,31,34]. The results from the
present study indicate that the AMPK activators AICAR and
metformin increase AMPK activity in trout myotubes, resulting
in an increase in GLUT4-mediated glucose uptake and possibly
also utilization, and suggest that AMPK may play an important
metabolic role in fish skeletal muscle, particularly under




Brown trout (Salmo trutta) weighing 8–20 g were supplied by the
Piscifactoria de Baga (Generalitat de Catalunya, Baga, Spain).
Animals were maintained in the facilities of the School of Biology
at the University of Barcelona in a closed-water flow circuit with
water at a temperature of 14uC. They were fed ad libitum with a
commercial diet and fasted 24 h prior to the experiments. The
experimental protocols used for trout in this study have been
reviewed and approved by the Ethics and Animal Welfare
Committee of the University of Barcelona, Spain.
Isolation and culture of trout muscle cells
Animals were sacrificed by a blow to the head and the skin was
sterilized by immersion in 70% ethanol for 30 seconds. Trout
muscle cell isolation and culture was performed as initially
described by Fauconneau and Paboeuf [35] with some modifica-
tions [30,31,34]. This cell system has been widely used and
validated by our group and others to study hormone and cytokine
action in undifferentiated and differentiated trout muscle cells in
vitro [29,31,34,36]. Briefly, the skin was removed and dorsal white
muscle was isolated in sterile conditions and collected in DMEM
at pH 7.4, containing 9 mM NaHCO3, 20 mM Hepes, 15% horse
serum, antibiotic-antimycotic cocktail (100 U/ml penicillin,
100 mg/ml streptomycin, 25 mg/ml amphotericin B) and 0.15%
gentamycin. The tissue was mechanically dissociated and then
enzymatically digested with a 0.2% collagenase solution in
DMEM for 1 h at 18uC and gentle shaking. After centrifugation
(300 g for 10 min at 15uC), the resulting pellet was washed in
DMEM without horse serum and was enzymatically digested twice
with a 0.1% trypsin solution in DMEM for 20 min at 18uC with
gentle shaking. The resulting cellular suspension was filtered
through 100 and 40 mm nylon filters. The obtained cells were
counted and plated on 12-well plates (BD Biosciences, Madrid,
Spain) at a density of 1.8–2610
6 cells/well. Plates were treated the
day before with poly-L-lysine and laminin to facilitate cell
adhesion and subsequent differentiation. Trout muscle cells were
maintained at 18uC in DMEM containing 9 mM NaHCO3,
20 mM Hepes, 10% FBS and antibiotic-antimycotic cocktail
(100 U/ml penicillin, 100 mg/ml streptomycin, 25 mg/ml ampho-
tericin B). After 24 h of plating, plates were washed to eliminate
non-adherent cells. Media was routinely renewed every second
day, while cultures were monitored by daily observation under an
inverted microscope (Zeiss Axiovert 25). Trout muscle cells were
cultured until they spontaneously differentiated into myotubes
after 8–10 days [31]. Media, enzymes and reagents used during
the isolation and culture were purchased from Sigma-Aldrich
(Tres Cantos, Spain).
Glucose uptake measurements in trout muscle cells
In order to determine the effects of AMPK activators on glucose
transport in myotubes, cells were incubated in the absence (Control)
or in the presence of AICAR (Sigma-Aldrich; 50, 250 and 500 mM)
or metformin (Sigma-Aldrich; 10, 100 and 500 mM). The specific
doses and incubation times used in the current study have been
optimized based on previous dose- and time-trials. Recombinant
human insulin (Sigma-Aldrich) was added at a concentration of
1 mM to the cells for 30 min prior to the glucose uptake assays as a
positive control, as previously described [31,34], and to study its
possible synergisticaction with theAMPK activators.In addition, 6-
[4-(2-Piperidin-1-ylethoxy) phenyl]-3-pyridin-4-ylpyrazolo [1,5-a]
pyrimidine (Compound C; Sigma-Aldrich), a protein kinase
Metabolic Effects of AMPK on Fish Skeletal Muscle
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concentration of 40 mM in the presence of the AMPK activators or
alone. AMPK activators and Compound C were applied directly to
cells plated in 12-well plates for 24 h after repeatedly washing the
cells with DMEM to remove the growth media.
Determination of 2-deoxyglucose (2-DG) uptake in trout muscle
cells was performed as previously described [29,31]. Briefly, cells
were washed twice with HEPES-buffered saline and were
incubated with the same buffer containing 50 mM 2-DG
(0.5 mCi/ml 2-[
3H]-DG) for 30 min at 18uC. Subsequently, cells
were rinsed three times with ice-cold PBS solution (154 mM NaCl,
5.6 mM Na2HPO4, 1.1 mM KH2PO4) containing 50 mM D-
glucose. Finally, cells were lysed with 0.05 N NaOH and lysates
were counted with scintillation liquid in a b-counter (Packard
Bioscience, Meriden, CT). Nonspecific uptake was carried out in
the presence of cytochalasin B (50 mM) during the assay, and these
values were subtracted from all other values. Protein content in the
lysates was measured using the Bio-Rad Protein Assay kit (Bio-
Rad, Barcelona, Spain). Glucose uptake was measured in
triplicate, normalized to total protein and expressed as fold
induction with respect to non-stimulated cells.
The viability of trout myotubes was assessed by determining
LDH activity released into the culture media of myotubes
incubated for 24 h with AMPK activators and the AMPK
inhibitor as described above. LDH activity was measured using
a commercial kit (Spinreact, Sant Esteve de Bas, Girona, Spain)
following the manufacturer’s instructions. No statistically signifi-
cant differences in the levels of LDH activity in the media were
found when myotubes were exposed for 24 h to AICAR,
metformin and/or Compound C with respect to control values
(data not shown).
Culture and cell surface labeling of L6 cells expressing
brown trout GLUT4
In order to determine if the cell surface levels of brown trout
GLUT4 increase in response to AMPK activators in skeletal
muscle cells, we used a rat skeletal muscle cell line L6 stably
expressing brown trout GLUT4 harboring an exofacial myc
epitope (btGLUT4myc) that has been used previously by our
group to study the traffic characteristics of brown trout GLUT4
[29]. Briefly, L6-btGLUT4myc myoblasts were maintained in a-
MEM supplemented with 10% FBS and 1% antibiotic/
antimycotic solution (100 U/ml penicillin, 100 mg/ml strepto-
mycin, 25 mg/ml amphotericin B) in a humidified atmosphere of
air and 5% CO2 at 37uC. Myotubes obtained by differentiating
L6-btGLUT4myc myoblasts in media supplemented with 2%
FBS within five days after seeding were serum-starved for two
hours and subsequently treated with AICAR (2 mM) or
metformin (1 mM) for 18 h. The doses of the AMPK activators
used for these experiments were chosen based of the effective
doses reported in the literature to affect GLUT4 traffic in
mammalian cells [37,38]. As a positive control, cells were treated
for 20 min with 100 nM human insulin, which stimulates
btGLUT4 translocation in this cell line [29]. Media was removed
and cells were washed three times with ice-cold PBS supple-
mented with 1 mM CaCl2 and 1 mM MgCl2 at 4uC( P B S +,
pH 7.4). Cells were then fixed with 3% paraformaldehyde for
15 min on ice and quenched with 100 mM glycine for 10 min.
To label cell surface btGLUT4myc, cells were blocked in 5%
goat serum in PBS+ for 10 min, and then incubated with a-myc
antibody solution (1.0 mg/ml in PBS+ with 5% goat serum) for
1 h at room temperature. Following labeling, excess anti-myc
antibodies were removed by extensive washing in ice-cold PBS+.
Cell surface GLUT4-bound anti-myc antibodies were probed
with HRP-conjugated secondary antibodies followed by detec-
tion of bound HRP by the colorimetric o-phenylenediamide
assay, as previously described [39]. The fraction of btGLUT4-
myc on the cell surface was measured in triplicate and expressed
as fold induction with respect to non-stimulated cells and
normalized to total protein.
Determination of AMPK activity
In order to detect the activation of endogenous AMPK by
synthetic compounds, trout myotubes were incubated in the
absence or presence of AICAR (250 mM) or metformin (10 mM)
for 24 h at the doses observed to stimulate glucose uptake in this
cell system. Cells were washed and scraped from the plates with
PBS and lysates were obtained using ice-cold RIPA buffer in the
presence of protease (10 ml/ml) and phosphatase inhibitor
cocktails (10 ml/ml), according to the manufacturer’s instructions
(Sigma-Aldrich). Protein content in the lysates was measured
using the Bio-Rad Protein Assay kit (Bio-Rad). AMPK activity in
lysates from trout myotubes was determined using the CycLex
AMPK Kinase Assay Kit (CycLex Co., Ltd., Nagano, Japan).
Briefly, samples were incubated for 30 min at 30uC in the
presence of ATP (50 mM) in a plate pre-coated with a substrate
peptide, corresponding to mouse IRS-1. AMPK activity in cell
lysates was measured by monitoring the phosphorylation of Ser-
789 in IRS-1 using an anti-mouse phospho-Ser-789 IRS-1
monoclonal antibody and peroxidase-coupled anti-mouse IgG
antibody. Conversion of the chromogenic substrate tetra-
methylbenzidine was quantified by measuring changes in
absorbance at 450 nm. AMPK activity (specific kinase activity)
was calculated as the difference between the absorbance
measured in the absence or in the presence of Compound C
(10 mM). Activity was measured in duplicates, normalized to total
protein in the cell lysates, and expressed as fold induction with
respect to non-stimulated cells.
Identification of AMPK subunits in trout skeletal muscle
cells by Western blotting
Western blot analyses were conducted using lysates from trout
myotubes (as described above) and from C2C12 myotubes, used
as a positive control. Myotube lysates (20–40 mg protein) were
diluted in Laemmli sample buffer, heated for 5 min at 95uC, and
centrifuged at 12000 g for 5 min. Proteins from the supernatant
and protein standards (Precision Plus, BioRad, Spain) were
loaded and separated on 12% SDS-PAGE precast gels using a
Mini-Protean system (BioRad, Spain) for 1–2 h at 100 V and
then transferred to a polyvinylidene difluoride (PVDF) membrane
(Millipore, Madrid, Spain). The membrane was blocked with
blocking buffer (20 mM Tris-HCl, 150 mM NaCl, 0.05%
Tween-20, pH 7.6) containing 5% (w/v) non-fat dry milk for
1 h. The membrane was washed several times in blocking buffer
and incubated overnight at 4uC with rabbit antibodies against the
different subunits of human AMPK (a1, a2, b1, b2, c1, c2 and c3)
AMPK Subunit Antibody Sampler Kit, Cell Signaling, Barce-
lona, Spain), diluted to 1:1000 in blocking buffer containing 5%
Bovine Serum Albumin (BSA, w/v) under continuous shaking.
After three washes, the membrane was incubated with a
secondary antibody against rabbit IgG conjugated with horse-
radish peroxidase (Cell Signaling, Barcelona, Spain) diluted
1:2000 in TBST buffer containing 5% BSA. Immune complexes
were detected using a chemiluminescent substrate (Supersignal
West Pico, ThermoScientific, Spain) according to the manufac-
ture’s instructions and visualized with a luminescent image
analyzer (FujiFilm LAS-3000).
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To investigate the effect of AMPK activators on glycogen
storage, trout myotubes were incubated with AICAR (250 mM),
metformin (10 mM) or media alone (Control) for 24 h. Cell lysates
were obtained as described in the previous section and used to
assay glycogen content by the amyloglucosidase hydrolysis method
[40]. The amount of glucose obtained after glycogen breakdown in
trout myotube lysates, after subtracting free glucose levels, was
measured in triplicate using a commercial assay kit (SpinReact,
Spain), and normalized to the total amount of protein in the cell
lysates.
Quantification of gene expression by qPCR
I no r d e rt ot e s tt h ee f f e c t so fA M P Ka g o n i s t so nt h e
expression of genes regulating glucose utilization, including
glucose transporters (GLUT1 and GLUT4), key enzymes in
glucose metabolism (hexokinase (HK), 6-phosphofructokinase (6-
P F K ) ,p y r u v a t ek i n a s e( P K ) ,g l y cogen synthase (GS), citrate
synthase (CS)), and the transcriptional coactivator peroxisome
proliferator-activated receptor c coactivator 1a (PGC-1a,t r o u t
myotubes were incubated with AICAR (250 mM), metformin
(10 mM) or media alone (Control). After a 24 h incubation, total
RNA was extracted from cultured myotubes using Trizol
reagent (Invitrogen, Barcelona, Spain), and reverse-transcribed
to cDNA using SuperScript III Transcriptase (Invitrogen),
oligo(dT) primer and random hexamer primers (Promega,
Barcelona, Spain), according to the manufacturer’s protocols.
Primer sequences, amplicon sizes and GenBank accession
numbers of the target genes are presented in Table 1. For the
amplification of trout 6-PFK, GS, CS and PGC-1a genes,
primers were designed using the Genamics Expression software.
Primers for the amplification of trout glucose transporters
GLUT1 and GLUT4 utilized in this study were previously
reported by Diaz et al. [31] and Planas et al. [27], respectively.
Primers used for the amplification of HK and PK were reported
by Panserat et al. [41]. The qPCR reactions contained 10 mlo f
SYBR GreenER qPCR SuperMix (Invitrogen), 500 nM of
forward and reverse primers, 3 mlR N a s e / D N a s e - f r e ew a t e r
and 5 ml of template DNA (cDNA at a 1:25 dilution or plasmid
DNA), in a final volume of 20 ml .T h er e a c t i o n sw e r er u ni na
MyiQ Real-Time PCR Detection System (Bio-Rad) using the
following protocol: 2 min at 50uC, 8 min at 95uC, followed by
40 cycles of 15 sec denaturation at 95uCa n d3 0 s e ca tt h e
temperature included in Table 1 for each pair of primers, and a
final melting curve of 81 cycles from 55uCt o9 5 uC( 0 . 5 uC
increments every 10 sec). All the samples were run in triplicate
and fluorescence was measured at the end of every extension
step. Fluorescence readings were used to estimate the Ct values
used to calculate the number of copies of the gene of interest.
Changes in HK, 6-PFK, GS, CS and PGC-1a expression were
analyzed using the quantification method by qPCR described by
Livak and Schmittgen [42]. In this method, values for each
sample were expressed as fold change, calculated relative to
control group and normalized for each gene against 18S
ribosomal RNA as the reference gene. Expression of 18S was
not affected by any of the treatments (data not shown). Changes
in GLUT1 and GLUT4 gene expression by qPCR was analyzed
according to the method described by Whelan et al. [43]. In this
method, the Ct values were used to calculate copy numbers with
standard plots constructed for each target gene using specific
primers and serial dilutions (10
24 to 10
29)o fp l a s m i dD N A
corresponding to cloned PCR products into the pGEM-T Easy
vector (Promega), which was previously quantified using a
QubitTM fluorometer (Invitrogen). The Ct values were plotted
against the logarithm of their initial template copy numbers,
generating a standard curve by linear regression of the plotted
points that are utilized for the calculations. All the standard
curves exhibited correlation coefficients higher than 0.99, and
efficiencies were greater than 99%.
Table 1. Sequences of primers used in gene expression analyses by qPCR (F: Forward; R: Reverse).
GenBank Gene name Primer sequence (59-39) Amplicon size (bp)
AF247728 GLUT1 (F) AATATCGACAAGCCACGCTG 270
(R) GAGAAGGAGCCGAAGATACC
AF247395 GLUT4 (F) GTGCCAGGCTTATTGTCCATATTC 357
(R) TAGAGAAGATGGCTACCGACAG
AY864082.1 HK (F) CTGGGACGCTGAAGACCAGA 159
(R) CGGTGCTGCATACCTCCTTG
AM083785 6-PFK (F) GATGGGAGTGGAGGCTGTGAT 239
(R) CTGGAGGGTTGATGTGGGCTA
AF246146.1 PK (F) GTCCAATGACCCTACTGAGG 306
(R) CCTGTCTTGAAGAAGCCCCT
BT073381.1 GS (F) CGTGGTGAGAGGAAGGAACTGAGC 236
(R) CCGTTGAGACCGTGGAGACA
TC89195 CS (F) CAACCAACCTCACTCATCACCATA 133
(R) GCAGCAGAAGCAGCCCATAA
CA368123 PGC-1a (F) CTCCAAGCACTACAAAAACCCAACT 127
(R) CACCACATCCCAAACACCAGA
AF308735 18S (F) CGGAGGTTCGAAGACGATCA 62
(R) TCGCTAGTTGGCATCGTTTAT
doi:10.1371/journal.pone.0031219.t001
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Values are given as mean 6 SE. Analysis of differences between
groups was performed by the Mann–Whitney Rank Sum Test and
were considered statistically significant when P,0.05.
Results
Identification of AMPK subunits in trout myotubes
In order to identify the presence of the AMPK heterotrimeric
(a, b, c) protein complex in the skeletal muscle of trout, antibodies
to the catalytic (a1 and a2) and regulatory subunits (b1, b2, c1, c2
and c3) of human AMPK were used for Western blotting with
lysates from trout myotubes. As shown in Figure 1, immunore-
active proteins of approximately 63 kDa, 37 kDa and 40 kDa
were detected in trout myotubes with antibodies to the a1, b2 and
c1 subunits of AMPK, respectively. As a positive control, these
antibodies also detected the a1, b2 and c1 AMPK subunits in
C2C12 myotubes at their expected molecular sizes, which were
similar to the molecular sizes of the three trout proteins identified.
However, we were unable to detect the a2, b1, c2 and c3 subunits
of AMPK in trout myotubes, although they were all present in the
positive control (data not shown).
AMPK activators stimulate glucose uptake in trout
myotubes
As a first step to investigate the possible role of AMPK in
glucose metabolism in fish skeletal muscle, we examined the effects
of two well-described AMPK activators in mammals (i.e. AICAR
and metformin) on glucose uptake in trout myotubes. We first
incubated the cells for 24 h in the presence or absence of different
doses of AICAR (50, 250 and 500 mM) and observed that this
compound significantly stimulated glucose uptake in myotubes
only at a dose of 250 mM (1.6 fold, P,0.01) (Fig. 2). Similarly,
incubation of trout myotubes with metformin (at doses of 10, 100
and 500 mM) resulted in a statistically significant stimulation of
glucose uptake at all doses tested (1.3, 1.2 and 1.4 fold respectively;
P,0.05) (Fig. 3). AICAR and metformin (at their maximally
effective doses) were equally or even more potent than insulin in
stimulating glucose uptake by trout myotubes. Therefore, our
results suggest that AMPK activators shown to stimulate glucose
uptake in mammalian muscle cells are also effective in stimulating
glucose uptake in trout myotubes. Phenformin, another biguanide
known to increase glucose uptake in mammalian skeletal muscle
cells by indirectly increasing AMPK activity, also stimulated
glucose uptake in brown trout myotubes (data not shown).
Therefore, these observations led us to hypothesize that the
AMPK activators tested may have stimulated glucose uptake by
increasing AMPK activity in trout muscle cells.
AMPK activators combined with insulin do not increase
further glucose uptake in trout myotubes
In order to examine if AMPK activators had an additive or
synergistic effect with insulin on glucose uptake by trout myotubes,
cells were incubated with AICAR (250 mM) or metformin (10 mM)
for 24 h in the presence or absence of insulin (1 mM) during the
last 30 min of the incubation, as we had shown in previous studies
that glucose uptake in trout myotubes was stimulated by insulin
under such conditions [30,31]. We observed that the combined
presence of AMPK activators and insulin did not significantly
stimulate glucose uptake in trout myotubes when compared to the
values obtained when cells were incubated with the same AMPK
activators alone (Fig. 4). These results indicate that AMPK
activators and insulin do not have additive or synergistic effects on
glucose uptake in trout muscle cells.
Compound C abrogates the stimulatory effects of AMPK
activators on glucose uptake in trout myotubes
In order to provide evidence for the involvement of AMPK
activity in the stimulatory action of AMPK activators on glucose
uptake in trout myotubes, we incubated the cells with AICAR or
metformin in the presence of Compound C, a protein kinase
inhibitor that inhibits AMPK activity [8] and that has been shown
to be a useful tool to study the function of AMPK in skeletal
muscle cells [44]. In support of the hypothesis that AMPK
activators may have stimulated glucose uptake by increasing
AMPK activity in brown trout myotubes, Compound C (40 mM)
caused a complete and significant (P,0.05) inhibition of the
stimulatory effects of AICAR (250 mM) and metformin (10 mM) on
glucose uptake (Figs. 2 and 3). Compound C alone did not have
any effect on basal glucose uptake (Figs. 2 and 3), suggesting that
AMPK activity may not be required for the entry of glucose into
trout myotubes under basal, non-stimulated conditions.
AMPK activators increase AMPK activity in trout
myotubes
To provide further evidence for the possible involvement of
AMPK in the action of AMPK activators on glucose uptake, we
analyzed the effects of AICAR and metformin on the activity of
AMPK in trout myotubes at the doses shown to significantly
stimulate glucose uptake (250 mM and 10 mM, respectively; Figs. 2
and 3). We observed that the activity of AMPK measured in
brown trout myotubes was significantly increased in the presence
of AICAR (3.8 fold) or metformin (3 fold) when compared to that
measured in control, untreated myotubes (P,0.05, Fig. 5).
AMPK activators increase the cell surface levels of trout
GLUT4 in btGLUT4myc-expressing L6 cells
In view of the stimulatory effects of AMPK activators on glucose
uptake by trout myotubes and on the well-known stimulation of
Figure 1. Immunodetection of AMPK subunits in trout
myotubes. Western blots were performed with lysates from trout
myotubes and from C2C12 myotubes, used as a positive control,
subjected to SDS-PAGE (12%) and blotted onto PVDF membranes,
using commercial antibodies (at 1:1000) against the a1, b2 and c1
subunits of human AMPK. The molecular weight of the protein markers
is expressed in kDa.
doi:10.1371/journal.pone.0031219.g001
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31219Figure 2. Effects of AICAR on glucose uptake in trout myotubes. Cells were serum starved and stimulated for 24 h in the absence or presence
of different doses of AICAR (50, 250 and 500 mM). The effects of AICAR (250 mM) we also tested in the absence or presence of Compound C (CC,
40 mM). Insulin was used as a positive control (1 mM) during the last 30 min of the incubation. Glucose uptake was subsequently determined as
described in Materials and Methods. Results are expressed as fold stimulation above the control group, which was set to 1, and shown as the means
6 SE of six independent experiments, each performed in triplicate. The asterisk indicates significant differences from control, where different letters
indicate significant differences between treatment with or without the inhibitor (P,0.05).
doi:10.1371/journal.pone.0031219.g002
Figure 3. Effects of metformin on glucose uptake in trout myotubes. Cells were serum starved and stimulated for 24 h in the absence or
presence of different doses of metformin (10, 100 and 500 mM). The effects of metformin (10 mM) we also tested in the absence or presence of
Compound C (CC, 40 mM). Insulin was used as a positive control (1 mM) during the last 30 min of the incubation. Glucose uptake was subsequently
determined as described in Materials and Methods. Results are expressed as fold stimulation above the control group, which was set to 1, and shown
as the means 6 SE of six independent experiments, each performed in triplicate. The asterisk indicates significant differences from control, where
different letters indicate significant differences between treatment with or without the inhibitor (P,0.05).
doi:10.1371/journal.pone.0031219.g003
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cells [45,46], we hypothesized that AMPK activators may have
stimulated glucose uptake by modulating the cell surface levels of
brown trout GLUT4. In order to test this hypothesis, for lack of a
fish cell line, we used a mammalian L6 muscle cell line generated
by our group that stably expresses brown trout GLUT4 with an
exofacial myc epitope (btGLUT4myc) and that has been a useful
tool to study the traffic of trout GLUT4 in muscle cells [29,34].
Using this cell line, we have previously reported that the cell
surface levels of btGLUT4 increase in response to extracellular
factors (e.g. insulin and tumor necrosis factor alpha) that stimulate
glucose uptake in trout muscle cells [29,34]. Our results indicate
Figure 4. Effects of AMPK activators and insulin on glucose uptake in trout myotubes. Cells were serum starved and stimulated for 24 h in
the absence or presence of different doses of AICAR (250 mM) or metformin (10 mM) and with or without insulin (1 mM), which was added during the
last 30 min of the incubation. Glucose uptake was subsequently determined as described in Materials and Methods. Results are expressed as fold
stimulation above the control group, which was set to 1, and shown as the means 6 SE of six independent experiments, each performed in triplicate.
The asterisk indicates significant differences from control (P,0.05).
doi:10.1371/journal.pone.0031219.g004
Figure 5. Effects of AMPK activators on AMPK activity in trout myotubes. Cells were serum starved and stimulated for 24 h in the absence
or presence of AICAR (250 mM) or metformin (10 mM). AMPK activity was subsequently determined in the cell lysates as described in Materials and
Methods. Results are expressed as fold stimulation above the control group, which was set to 1, and shown as means 6 SE of five independent
experiments, each performed in duplicate. The asterisk indicates significant differences from control (P,0.05).
doi:10.1371/journal.pone.0031219.g005
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(2 mM; a dose shown to increase the cell surface levels of rat
GLUT4 in ratGLUT4myc L6 cells; [38]) and metformin (1 mM)
for 18 h displayed a modest but statistically (P,0.001) significant
increase (1.2 fold) in the amount of btGLUT4 at the cell surface
(Fig. 6).
AMPK activators increase GLUT4, but not GLUT1, mRNA
levels in trout myotubes
In order to determine the effects of AMPK activators on glucose
transporter expression in brown trout muscle cells, we investigated
the effects of AICAR (250 mM) and metformin (10 mM) on the
mRNA levels of GLUT1 and GLUT4, two genes known to be
expressed in trout skeletal muscle and to be regulated under
nutritional and hormonal manipulation [27,28,31]. Trout myo-
tubes incubated for 24 h with AICAR or metformin displayed
significantly higher GLUT4 mRNA levels with respect to
untreated myotubes (2.5 and 3.6 fold, respectively, Figure 7A,
P,0.05). However, the mRNA levels of GLUT1 in trout
myotubes were not affected by any of the AMPK activators tested
(Fig. 7B).
AMPK activators do not alter glycogen content in trout
myotubes
In view of the stimulatory effects of AMPK activators on
glucose uptake and on the possible involvement of GLUT4 in this
process in trout myotubes, we investigated if these effects were
accompanied by changes in the amount of glycogen stored in
those cells. Our results indicate that glycogen content was not
affected by AMPK activators since the levels of glycogen stored in
cells treated with AICAR (250 mM) or metformin (10 mM) were
not significantly different than in non-treated trout myotubes
(Fig. 8).
AICAR increases the mRNA levels of genes involved in
glucose disposal, generation of energy, and
transcriptional regulation in trout myotubes
In order to further investigate the possible fate of glucose taken
up by trout myotubes as a result of the pharmacological activation
of AMPK, given the similar effects of AICAR and metformin on
all other parameters examined, we evaluated the effects of AICAR
alone on the expression of several genes involved in glucose
utilization and the generation of energy, including HK (glucose
phosphorylation), 6-PFK and PK (glycolysis), GS (glycogen
synthesis) and CS (tricarboxylic acid (TCA) cycle). Furthermore,
we studied the effects of AICAR on the mRNA levels of PGC-1a a
transcriptional coactivator that is critical in the regulation of the
metabolism of the cell. Trout myotubes incubated for 24 h with
AICAR displayed significantly higher mRNA levels of HK, 6-
PFK, PK, CS and PGC-1a with respect to untreated myotubes
(1.8, 1.3, 1.2, 1.8 and 2.2 fold, respectively; Fig. 9). However,
consistent with the lack of change in glycogen levels, the mRNA
levels of GS in trout myotubes were not affected by AICAR (Fig. 9).
Discussion
Identification of the AMPK heterotrimeric complex in
trout skeletal muscle cells
AMPK, an enzyme with a key role in energy sensing and in the
regulation of energy balance, is a heterotrimeric protein complex
composed of a catalytic a subunit and two regulatory subunits: b
and c [47]. In order to investigate the potential role of AMPK in
regulating glucose metabolism in the skeletal muscle of fish, we
first set out to characterize the nature of the AMPK complex in
trout myotubes. Here we report for the first time on the
identification of AMPK complex; namely, the a1, b2 and c1
protein subunits of trout AMPK in skeletal muscle cells,
corresponding to proteins of approximately 63, 37 and 40 kDa
Figure 6. Effects of AMPK activators on trout GLUT4 cell surface levels in btGLUT4myc L6 cells. Cells were serum starved and stimulated
for 18 h in the absence or presence of AICAR (2 mM) or metformin (1 mM). Insulin (100 nM), used as a positive control, was added during the last
20 min of the incubation. The proportion of trout GLUT4myc at the cell surface relative to control was determined as described in Materials and
Methods. Results are expressed as fold stimulation above the control group, which was set to 1, and shown as means 6 SE of six independent
experiments, each performed in triplicate. The asterisk indicates significant differences from control (P,0.05).
doi:10.1371/journal.pone.0031219.g006
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cloned recently in rainbow trout [12].
AMPK may increase glucose uptake through a GLUT4-
mediated mechanism
From a functional point of view, in this study we report for the
first time in fish that pharmacological activation of endogenous
AMPK results in the stimulation of glucose uptake in skeletal
muscle cells. These results are in agreement with the well
established effects of AICAR and metformin as AMPK activators
in skeletal muscle of mammals, which cause a concomitant
increase in glucose uptake by the tissue [48,49]. In particular, the
adenosine analog AICAR increases glucose uptake in rat skeletal
muscle without large changes in ATP, ADP, or AMP concentra-
tions [22,23]. AICAR enters the cells by adenosine transporters
and is phosphorylated by adenosine kinase to ZMP, a mono-
phosphorylated derivative [50]. The increase of ZMP activates
AMPK [51], mimicking the multiple effects of AMP on the
enzyme, including its activation by allosteric regulation and
phosphorylation [52]. Incidentally, high levels of ZMP have been
reported to inhibit AMPK activity [51] which could explain the
lack of stimulatory effects of the highest dose of AICAR (500 mM)
tested on glucose uptake in trout myotubes. On the other hand,
Figure 7. Effects of AMPK activators on GLUT4 and GLUT1
expression in trout myotubes. Cells were serum starved and
stimulated for 24 h in the absence or presence of AICAR (250 mM) or
metformin (10 mM). Total RNA from trout myotubes was isolated and
reverse transcribed to cDNA. GLUT4 (A) and GLUT1 (B) mRNA
expression levels were determined by absolute qPCR quantification as
described in Materials and Methods. Results are expressed as fold
stimulation above the control group, which was set to 1, and shown as
means 6 SE of five independent experiments, each performed in
triplicate. The asterisk indicates significant differences from control
(P,0.05).
doi:10.1371/journal.pone.0031219.g007
Figure 8. Effects of AMPK activators on glycogen content in
trout myotubes. Cells were serum starved and stimulated for 24 h in
the absence or presence of AICAR (250 mM) or metformin (10 mM).
Glycogen content was subsequently determined in the cell lysates as
described in Materials and Methods. Results are expressed as nmoles of
glucose released from glycogen hydrolysis per mg of protein, and
shown as means 6 SE of five independent experiments, each
performed in triplicate.
doi:10.1371/journal.pone.0031219.g008
Figure 9. Effects of AICAR on hexokinase (HK), 6-phosphofruc-
tokinase (6-PFK), pyruvate kinase (PK), glycogen synthase (GS),
citrate synthase (CS), and peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PGC-1a) mRNA expres-
sion levels in trout myotubes. Cells were serum starved and
stimulated for 24 h in the absence or presence of AICAR (250 mM). Total
RNA from trout myotubes was isolated and reverse transcribed to
cDNA, and mRNA expression levels were determined by qPCR as
described in Materials and Methods. Results are expressed as fold
stimulation above the control group, which was set to 1, and shown as
means 6 SE of five independent experiments, each performed in
triplicate. The asterisk indicates significant differences from control
(P,0.05).
doi:10.1371/journal.pone.0031219.g009
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mitochondrial ATP synthesis and, therefore, by increasing cellular
AMP:ATP ratios [1]. Therefore, the stimulation of glucose uptake
in trout myotubes by two different and well-known AMPK
activators that operate through different mechanisms suggests that
they may activate endogenous AMPK in fish skeletal muscle cells.
Indeed, we demonstrate here that treatment of trout myotubes
with AICAR or metformin results in a significant increase in
AMPK activity, as in mammalian muscle cells [8,53]. Further
support for the hypothesis that AMPK activators may stimulate
glucose uptake in brown trout myotubes by activating endogenous
AMPK is derived by our results on the ability of Compound C, a
broadly used inhibitor of AMPK that binds to the ATP-binding
site on the enzyme [8], to completely block the effects of AICAR
and metformin on glucose uptake. It should be mentioned,
however, that despite it is well established in the literature that
AICAR effectively activates AMPK, this compound is known to
have effects on several non protein kinase targets [47], which
would lead to the possibility that AICAR may stimulate glucose
uptake in our cell system through mechanism(s), at least in part,
independent of AMPK. In the present study, several observations
support our hypothesis that the stimulatory effects of AICAR on
glucose uptake in trout myotubes are likely mediated by AMPK.
First, metformin, an unrelated compound that activates AMPK
through a completely different mechanism than AICAR, has
similar effects to AICAR on glucose uptake. Second, Compound
C, a broadly used AMPK inhibitor, completely blocked the
stimulatory effects of AICAR (and metformin) on glucose uptake.
Finally, AICAR and metformin both stimulated AMPK activity in
trout myotubes. Furthermore, in addition to the concerns
regarding the specificity of AICAR as a pharmacological tool to
study AMPK, concerns may arise by the use of Compound C,
since it has been reported to inhibit AMPK as well as other protein
kinases. However, we believe that our results obtained with trout
myotubes using this inhibitor can be attributed to the inhibition of
AMPK activity because Compound C completely reversed the
stimulatory effects of AICAR (which is not known to target other
protein kinases) on glucose uptake, a condition considered
evidence for a role for AMPK [47], as well as the effects of
metformin, and even phenformin (data not shown), on glucose
uptake. In support for the use of Compound C in studying the role
of AMPK in skeletal muscle cells, several studies have reported
identical results when blocking AMPK activity with Compound C
and when decreasing AMPKa subunit levels by siRNA in
mammalian cells [44,54].
The translocation of GLUT4 from an intracellular location to
the plasma membrane and transverse tubules is thought to be the
major mechanism by which exercise, AMPK activators and insulin
increase skeletal muscle glucose transport in mammals [55]. In the
present study, we propose that the enhanced glucose uptake by
AICAR and metformin in trout myotubes may be due to an
increase in the cell surface levels of GLUT4, as suggested by our
results using an L6 muscle cell line stably expressing brown trout
GLUT4 [29]. This heterologous (mammalian) cell system, for lack
of a homologous (fish) cell system, has proven to be a very useful
model to study the traffic characteristics of brown trout GLUT4 in
skeletal muscle cells [29,34]. Although the increase in the cell
surface levels of btGLUT4 by AICAR and metformin measured in
our study was modest (approximately a 20% increase over
controls), a similar mechanism involving increased GLUT4
translocation and, therefore, glucose uptake due to the activation
of AMPK by AICAR and metformin, has been described in the
mammalian muscle. In rats, AICAR administration causes a 1.5 to
2 fold increase of GLUT4 protein in the muscle [7], a 1.2 fold
increase in the GLUT4 pool at the plasma membrane in the
hindlimb [7] and a 57% increase in the sarcolemma to
intracellular content ratio for GLUT4 in the myocardial muscle
of AICAR-infused rats [56]. In rat cardiomyocytes, metformin has
been shown to increase glucose uptake (5 fold) by increasing by
50% the retention time of GLUT4 at the plasma membrane [57].
Moreover, AICAR and metformin treatment provoked acute
increases in the translocation of GLUT4 to the plasma membrane
in mice gastrocnemius muscle and in L6 myotubes [37]. In
addition to the increase in trout GLUT4 cell surface levels by
AICAR and metformin, we show in this study that these two
AMPK activators also increase GLUT4 mRNA levels in trout
myotubes. Therefore, we believe that the observed increase in
glucose uptake under the stimulus of AICAR and metformin in
trout myotubes could be due, at least in part, to an increase in the
cell surface and mRNA levels of GLUT4. In rats, a day after 6 h of
swimming, GLUT4 expression in muscle was increased by 2 fold
[58], whereas an in vitro incubation of rat muscle with 500 mM
AICAR for 18 h increased GLUT4 expression by 1.5–1.6 fold
[59], showing that AMPK activators enhance GLUT4 expression
in this tissue. Interestingly, GLUT1 expression was not affected by
AMPK activators in trout myotubes, suggesting that the observed
increase in glucose uptake as a result of AMPK activation may be
mediated primarily through GLUT4. A recent study examining
the in vivo effects of metformin administration in rainbow trout
indicated that this AMPK activator lowers blood glucose levels
and increases GLUT4 expression in white skeletal muscle [33].
Our results on the direct stimulatory effects of AMPK activators
on AMPK activity, glucose uptake and cell surface and mRNA
levels of trout GLUT4 in skeletal muscle cells suggest that the
reported hypoglycemic effects of metformin administration in
rainbow trout [33] may result from the direct action of this
compound on white skeletal muscle, increasing its ability to take
up glucose through a mechanism involving AMPK activation and
increased GLUT4 cell surface and mRNA levels (Fig. 10).
AMPK activation may drive glucose towards the
glycolytic pathway for energy generation
In skeletal muscle, once glucose enters the cells it is rapidly
phosphorylated to glucose-6-phosphate (G6P) by HK. The fate of
G6P is then two-fold: G6P can either be directed towards the
synthesis of glycogen or, alternatively, G6P can be used for the
direct generation of ATP by glycolysis and the TCA cycle. Our
results show that pharmacological activation of AMPK by AICAR
increased the mRNA levels of HK in trout myotubes, suggesting
that activation of AMPK stimulates the entry as well as the
metabolism of glucose in trout skeletal muscle cells, as it is the case
in the mammalian muscle in response to exercise [55,60]. Our
results are also consistent with those of a recent study showing that
in vivo administration of metformin in rainbow trout fed a high-
carbohydrate diet increases the mRNA levels and activity of HK
in white skeletal muscle [33]. Interestingly, our results also show
that the glycogen content in trout myotubes was not affected by
the AMPK activators AICAR and metformin and that the mRNA
levels of GS were not affected by AICAR. Our results are
consistent with studies in mammals that have shown that AMPK
activation induces the phosphorylation of GS, decreasing its
activity and, consequently, glycogen synthesis in skeletal muscle
[61,62]. However, other studies in mammals have reported the
opposite effect, with AICAR stimulating allosterically GS by
increasing the concentration of glucose-6-phosphate and, there-
fore, overriding the inhibitory phosphorylation of GS [63,64].
Although there is no direct evidence in fish on the regulation of GS
activity by AMPK activators, the inability of AMPK activators to
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that pharmacological activation of AMPK does not result in the
use of glucose for glycogen synthesis. In contrast, the stimulation
by AICAR of the mRNA levels of 6-PFK and PK, two key
enzymes in the glycolytic pathway, and of CS, an enzyme
controlling one of the flux-determining steps of the TCA cycle,
strongly suggests that AMPK activation in trout myotubes may
turn on metabolic pathways that lead to the generation of energy
from glucose. Therefore, in fish skeletal muscle cells, pharmaco-
logical activation of AMPK may result in increased glucose uptake
and flux through glycolysis, as in mammals [65], rather than
through glycogenesis (Fig. 10).
Although we did not measure changes in ATP concentration in
trout myotubes in our experiments, there is strong evidence that
cellular ATP levels are relatively stable in vertebrates, despite
significant changes in pathway fluxes and energy provision to the
muscle [66]. Therefore, the increase in glucose uptake and the lack
of change in glycogen content produced by the activation of
AMPK by AICAR and metformin suggest that an inhibitory
mechanism may be present to avoid a build-up of ATP in the cell.
Such mechanisms may include the allosteric down-regulation of
AMPK activity by ATP levels [67], the dephosphorylation of the
enzyme by protein phosphatases 2A (PP2A) and 2C [68,69,70] or
its inhibition by the serine/threonine protein kinase Akt [71].
The mechanisms by which AICAR and metformin regulate the
transcription of GLUT4 have been described in the mammalian
muscle and may involve the phosphorylation of PGC-1a by
AMPK [72,73] and the binding of myocyte enhancer factor 2 to
the GLUT4 promoter to increase the transcription of the GLUT4
gene [74,75]. Additionally, recent studies suggest that exercise and
pharmacological activation of AMPK also serve as important
signals in regulating the expression of PGC-1a in skeletal muscle
[76,77]. PGC-1a is also involved in the transcriptional regulation
of several genes implicated in the generation of ATP, mainly from
oxidative metabolism [78,79]. In particular, PGC-1a is known to
mediate the stimulatory effects of AMPK on fatty acid oxidation in
skeletal muscle [80]. In the present study we show that AICAR
increases PGC-1a mRNA levels in trout myotubes (Fig. 9), which
agrees with the described effect of this AMPK activator in the
mammalian muscle [81,82]. The observation that AMPK
activation in trout myotubes results in increased PGC-1a and
CS mRNA levels, coupled with recent data showing that exercise
increases PGC-1a and CS mRNA levels in the skeletal muscle of
zebrafish [83], suggest that AMPK could be involved in mediating
the stimulatory effects of exercise on PGC-1a and CS expression
in fish skeletal muscle. It will be interesting to determine in future
studies if the pharmacological activation of AMPK in trout
myotubes, or even in vivo conditions that may result in increased
AMPK activity (e.g. swimming-induced exercise), could increase
fatty acid oxidation.
Conclusions and Perspectives
In summary, AICAR and metformin, two compounds that are
effective stimulators of muscle AMPK activity in mammals, have
been shown to stimulate AMPK activity and increase glucose
transport in trout myotubes through a mechanism that appears to
be mediated by GLUT4. Furthermore, AMPK activation in trout
myotubes results in increased expression of key genes involved in
ATP generation from glucose through glycolysis (Fig. 10). The
results from the present study suggest that the metabolic role of
AMPK in skeletal muscle appears to have been conserved
throughout evolution from fish to mammals, evidencing the
importance of AMPK in energy regulation in vertebrates.
Furthermore, our observations provide essential information to
test, in future studies, the hypothesis that AMPK may be a
potentially important intermediary in the signaling cascade
leading to contraction-stimulated glucose transport and utiliza-
tion in fish skeletal muscle. Specifically, research must be
conducted to determine whether AMPK plays an important
metabolic and energy sensing role during swimming-induced
exercise in fish.
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Figure 10. Proposed model for the role of AMPK in fish skeletal
muscle cells. We propose that activation of endogenous AMPK by
pharmacological activators (i.e. AICAR or metformin) results in increased
glucose uptake by fish skeletal muscle cells through two mechanisms
involving GLUT4: 1) increased mRNA levels of GLUT4 (possibly through
the increased expression of peroxisome proliferator-activated receptor
c coactivator 1a or PGC-1a) and 2) stimulation of the translocation of
GLUT4 to the plasma membrane. Furthermore, we propose that
pharmacological activation of AMPK may also increase glucose
utilization by stimulating expression of hexokinase (HK), 6-phospho-
fuctokinase (6-PFK), pyruvate kinase (PK) and citrate synthase (CS)
mRNA levels. Future studies should be devoted to examine the
possibility that AMPK may be activated as a result of the contraction of
skeletal muscle fibers in swimming fish.
doi:10.1371/journal.pone.0031219.g010
Metabolic Effects of AMPK on Fish Skeletal Muscle
PLoS ONE | www.plosone.org 11 February 2012 | Volume 7 | Issue 2 | e31219References
1. Hardie D, Sakamoto K (2006) AMPK: a key sensor of fuel and energy status in
skeletal muscle. Physiology 21: 48–60.
2. Richter EA, Ruderman NB (2009) AMPK and the biochemistry of exercise:
implications for human health and disease. Biochem J 418: 261–275.
3. de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, et al. (2007) Fuel
economy in food-deprived skeletal muscle: signaling pathways and regulatory
mechanisms. FASEB J 21: 3431–3441.
4. Hochachka PW, Matheson GO (1992) Regulating ATP turnover rates over
broad dynamic work ranges in skeletal muscles. J Appl Physiol 73: 1697–1703.
5. Jessen N, Goodyear LJ (2005) Contraction signaling to glucose transport in
skeletal muscle. J Appl Physiol 99: 330–337.
6. Winder WW (2001) Energy-sensing and signaling by AMP-activated protein
kinase in skeletal muscle. J Appl Physiol 91: 1017–1028.
7. Holmes BF, Kurth-Kraczek EJ, Winder WW (1999) Chronic activation of 59-
AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in
muscle. J Appl Physiol 87: 1990–1995.
8. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated
protein kinase in mechanism of metformin action. J Clin Invest 108: 1167–1174.
9. Jibb LA, Richards JG (2008) AMP-activated protein kinase activity during
metabolic rate depression in the hypoxic goldfish, Carassius auratus. J Exp Biol
211: 3111–3122.
10. Stenslokken K-O, Ellefsen S, Stecyk JAW, Dahl MB, Nilsson GE, et al. (2008)
Differential regulation of AMP-activated kinase and AKT kinase in response to
oxygen availability in crucian carp (Carassius carassius). Am J Physiol Regul Integr
Comp Physiol 295: 1803–1814.
11. Lau G, Richards J (2011) AMP-activated protein kinase plays a role in initiating
metabolic rate suppression in goldfish hepatocytes. J Comp Physiol B. pp 1–13.
12. Polakof S, Panserat S, Craig P, Martyres D, Plagnes-Juan E, et al. (2011) The
metabolic consequences of hepatic AMP-kinase phosphorylation in rainbow
trout. PLoS ONE 6: e20228.
13. Holloszy JO, Hansen PA (1996) Regulation of glucose transport into skeletal
muscle. Rev Physiol Biochem Pharmacol 128: 99–193.
14. Kubo K, Foley JE (1986) Rate-limiting steps for insulin-mediated glucose uptake
into perfused rat hindlimb. Am J Physiol Endocrinol Metab 250: 100–102.
15. Klip A, Volchuk A, He L, Tsakiridis T (1996) The glucose transporters of
skeletal muscle. Cell Develop Biol 7: 229–237.
16. Coderre L, Kandror KV, Vallega G, Pilch PF (1995) Identification and
characterization of an exercise-sensitive pool of glucose transporters in skeletal
muscle. J Biol Chem 270: 27584–27588.
17. Roy D, Marette A (1996) Exercise induces the translocation of GLUT4 to
transverse tubules from an intracellular pool in rat skeletal muscle. Biochem
Biophys Res Commun 223: 147–152.
18. Neufer PD, Dohm GL (1993) Exercise induces a transient increase in
transcription of the GLUT-4 gene in skeletal muscle. Am J Physiol Cell Physiol
265: 1597–1603.
19. MacLean PS, Zheng D, Jones JP, Olson AL, Dohm GL (2002) Exercise-induced
transcription of the muscle glucose transporter (GLUT4) gene. Biochem Biophys
Res Commun 292: 409–414.
20. Murgia M, Jensen TE, Cusinato M, Garcia M, Richter EA, et al. (2009)
Multiple signalling pathways redundantly control glucose transporter GLUT4
gene transcription in skeletal muscle. J Physiol 587: 4319–4327.
21. Holloszy J (2005) Exercise-induced increase in muscle insulin sensitivity. J Appl
Physiol 99: 338–343.
22. Bergeron R, Russell RR, Young LH, Ren J-M, Marcucci M, et al. (1999) Effect
of AMPK activation on muscle glucose metabolism in conscious rats.
Am J Physiol Endocrinol Metab 276: 938–944.
23. Merrill GF, Kurth EJ, Hardie DG, Winder WW (1997) AICA riboside increases
AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat
muscle. Am J Physiol Endocrinol Metab 273: 1107–1112.
24. Jessen N, Pold R, Buhl ES, Jensen LS, Schmitz O, et al. (2003) Effects of AICAR
and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4
content in rat muscles. J Appl Physiol 94: 1373–1379.
25. Bonen A (2009) PGC-1a-induced improvements in skeletal muscle metabolism
and insulin sensitivity. Appl Physiol Nut Metab 34: 307–308.
26. Moon TW (2001) Glucose intolerance in teleost fish: fact or fiction? Comp
Biochem Physiol B 129: 243–249.
27. Planas JV, Capilla E, Gutierrez J (2000) Molecular identification of a glucose
transporter from fish muscle. FEBS Lett 481: 266–270.
28. Capilla E, Diaz M, Gutierrez J, Planas JV (2002) Physiological regulation of the
expression of a GLUT4 homolog in fish skeletal muscle. Am J Physiol
Endocrinol Metab 283: 44–49.
29. Diaz M, Antonescu CN, Capilla E, Klip A, Planas JV (2007) Fish glucose
transporter (GLUT)-4 differs from rat GLUT4 in its traffic characteristics but
can translocate to the cell surface in response to insulin in skeletal muscle cells.
Endocrinology 148: 5248–5257.
30. Diaz M, Capilla E, Planas JV (2007) Physiological regulation of glucose
transporter (GLUT4) protein content in brown trout (Salmo trutta) skeletal muscle.
J Exp Biol 210: 2346–2351.
31. Diaz M, Vraskou Y, Gutierrez J, Planas JV (2009) Expression of rainbow trout
glucose transporters GLUT1 and GLUT4 during in vivo muscle cell
differentiation and regulation by insulin and IGF-I. Am J Physiol Regul Integr
Comp Physiol 296: 794–800.
32. Hertz Y, Epstein N, Abraham M, Madar Z, Hepher B, et al. (1989) Effects of
metformin on plasma insulin, glucose metabolism and protein synthesis in the
common carp (Cyprinus carpio L.). Aquaculture 80: 175–187.
33. Polakof S, Moon T, Aguirre P, Skiba-Cassy S, Panserat S (2011) Glucose
homeostasis in rainbow trout fed a high-carbohydrate diet: metformin and
insulin interact in a tissue-dependent manner. Am J Physiol Reg Integr Comp
Physiol 300: 166–174.
34. Vraskou Y, Roher N, Diaz M, Antonescu CN, MacKenzie SA, et al. (2011)
Direct involvement of tumor necrosis factor-a in the regulation of glucose uptake
in rainbow trout muscle cells. Am J Physiol Regul Integr Comp Physiol 300:
716–723.
35. Fauconneau B, Paboeuf G (2000) Effect of fasting and refeeding on in vitro
muscle cell proliferation in rainbow trout (Oncorhynchus mykiss). Cell Tissue Res
301: 459–463.
36. Castillo J, Ammendrup-Johnsen I, Codina M, Navarro I, Gutierrez J (2006)
IGF-I and insulin receptor signal transduction in trout muscle cells. Am J Physiol
Regul Integr Comp Physiol 290: 1683–1690.
37. Sajan M, Bandyopadhyay G, Miura A, Standaert M, Nimal S, et al. (2010)
AICAR and metformin, but not exercise, increase muscle glucose transport
through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC.
Am J Physiol Endocrinol Metab 298: 179–192.
38. Thong F, Bilan P, Klip A (2007) The Rab GTPase-activating protein AS160
integrates Akt, protein kinase C, and AMP-activated protein kinase signals
regulating GLUT4 traffic. Diabetes 56: 414–423.
39. Wang Q, Khayat Z, Kishi K, Ebina Y, Klip A (1998) GLUT4 translocation by
insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS
Lett 427: 193–197.
40. Keppler D, Decker K (1974) Glycogen. Determination with amyloglucosidase.
In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: Academic
Press. pp 1127–1131.
41. Panserat S, Skiba-Cassy S, Seiliez I, Lansard M, Plagnes-Juan E, et al. (2009)
Metformin improves postprandial glucose homeostasis in rainbow trout fed
dietary carbohydrates: a link with the induction of hepatic lipogenic capacities?
Am J Physiol Regul Integr Comp Physiol 297: 707–715.
42. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2-[DD]CT method. Methods 25: 402–408.
43. Whelan JA, Russell NB, Whelan MA (2003) A method for the absolute
quantification of cDNA using real-time PCR. J Immunol Methods 278:
261–269.
44. Niu W, Bilan PJ, Ishikura S, Schertzer JD, Contreras-Ferrat A, et al. (2010)
Contraction-related stimuli regulate GLUT4 traffic in C2C12-GLUT4myc
skeletal muscle cells. Am J Physiol Endocrinol Metab 298: 1058–1071.
45. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW (1999) 59 AMP-
activated protein kinase activation causes GLUT4 translocation in skeletal
muscle. Diabetes 48: 1667–1671.
46. Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A (1992) Cellular mechanism
of metformin action involves glucose transporter translocation from an
intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology
131: 1165–1173.
47. Hardie D (2007) AMP-activated protein kinase as a drug target. Annu Rev
Pharmacol Toxicol 47: 185–210.
48. Jørgensen SB, Richter EA, Wojtaszewski JFP (2006) Role of AMPK in skeletal
muscle metabolic regulation and adaptation in relation to exercise. J Physiol 574:
17–31.
49. Musi N, Goodyear LJ (2003) AMP-activated protein kinase and muscle glucose
uptake. Acta Physiol Scand 178: 337–345.
50. Bontemps F, van den Berghe G, Hers HG (1986) Pathways of adenine
nucleotide catabolism in erythrocytes. J Clin Invest 77: 824–830.
51. Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 59-Aminoimidazole-4-
Carboxamide Ribonucleoside: A specific method for activating AMP-activated
protein kinase in intact cells? Eur J Biochem 229: 558–565.
52. Sabina R, Patterson D, Holmes E (1985) 59-Amino-4-imidazolecarboxamide
riboside (Z-riboside) metabolism in eukaryotic cells. J Biol Chem 260:
6107–6114.
53. Sakamoto K, Goransson O, Hardie DG, Alessi DR (2004) Activity of LKB1 and
AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and
AICAR. Am J Physiol Endocrinol Metab 287: 310–317.
54. Lira VA, Brown DL, Lira AK, Kavazis AN, Soltow QA, et al. (2010) Nitric
oxide and AMPK cooperatively regulate PGC-1a in skeletal muscle cells.
J Physiol 588: 3551–3566.
55. Rose AJ, Richter EA (2005) Skeletal muscle glucose uptake during exercise: How
is it regulated? Physiology 20: 260–270.
56. Russell RR, Bergeron R, Shulman GI, Young LH (1999) Translocation of
myocardial GLUT-4 and increased glucose uptake through activation of AMPK
by AICAR. Am J Physiol Heart Circ Physiol 277: 643–649.
57. Yang J, Holman GD (2006) Long-term metformin treatment stimulates
cardiomyocyte glucose transport through an AMP-activated protein kinase-
dependent reduction in GLUT4 endocytosis. Endocrinology 147: 2728–2736.
58. Ren J, Semenkovich C, Gulve E, Gao J, Holloszy J (1994) Exercise induces rapid
increases in GLUT4 expression, glucose transport capacity, and insulin-
stimulated glycogen storage in muscle. J Biol Chem 269: 14396–14401.
Metabolic Effects of AMPK on Fish Skeletal Muscle
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e3121959. Ojuka E, Nolte L, Holloszy J (2000) Increased expression of GLUT-4 and
hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl
Physiol 88: 1072–1075.
60. Zierath JR (2002) Invited Review: Exercise training-induced changes in insulin
signaling in skeletal muscle. J Appl Physiol 93: 773–781.
61. Miyamoto L, Toyoda T, Hayashi T, Yonemitsu S, Nakano M, et al. (2007)
Effect of acute activation of 59-AMP-activated protein kinase on glycogen
regulation in isolated rat skeletal muscle. J Appl Physiol 102: 1007–1013.
62. Wojtaszewski JFP, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA (2002)
Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-ribo-
side on AMP-activated protein kinase and glycogen synthase activities in
ratskeletal muscle. Diabetes 51: 284–292.
63. Aschenbach WG, Hirshman MF, Fujii N, Sakamoto K, Howlett KF, et al.
(2002) Effect of AICAR treatment on glycogen metabolism in skeletal muscle.
Diabetes 51: 567–573.
64. Hunter RW, Treebak JT, Wojtaszewski Jr. FP, Sakamoto K (2011) Molecular
mechanism by which AMP-activated protein kinase activation promotes
glycogen accumulation in muscle. Diabetes 60: 766–774.
65. Halse R, Fryer LGD, McCormack JG, Carling D, Yeaman SJ (2003) Regulation
of glycogen synthase by glucose and glycogen. Diabetes 52: 9–15.
66. Dobson GP, Hochachka PW (1987) Role of glycolysis in adenylate depletion and
repletion during work and recovery in teleost white muscle. J Exp Biol 129:
125–140.
67. Corton J, Gillespie J, Hawley S, Hardie D (1995) 5-aminoimidazole-4-
carboxamide ribonucleoside. A specific method for activating AMP-activated
protein kinase in intact cells? Eur J Biochem 229: 558–565.
68. Davies SP, Helps NR, Cohen PTW, Hardie DG (1995) 59-AMP inhibits
dephosphorylation, as well as promoting phosphorylation, of the AMP-activated
protein kinase. Studies using bacterially expressed human protein phosphatase-
2a and native bovine protein phosphatase-2Ac. FEBS Lett 377: 421–425.
69. Kudo N, Gillespie J, Kung L, Witters L, Schulz R, et al. (1996) Characterization
of 59AMP-activated protein kinase activity in the heart and its role in inhibiting
acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys
Acta 1301: 67–75.
70. Ravnskjaer K, Boergesen M, Dalgaard L, Mandrup S (2006) Glucose-induced
repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A
activation and AMPK inactivation. J Mol Endocrinol 36: 289–299.
71. Hahn-Windgassen A, Nogueira V, Chen C-C, Skeen JE, Sonenberg N, et al.
(2005) Akt activates the mammalian target of rapamycin by regulating cellular
ATP level and AMPK activity. J Biol Chem 280: 32081–32089.
72. Al-Khalili L, Forsgren M, Kannisto K, Zierath JR, Lo ¨nnqvist F, et al. (2005)
Enhanced insulin-stimulated glycogen synthesis in response to insulin,
metformin or rosiglitazone is associated with increased mRNA expression of
GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1.
Diabetologia 48: 1173–1179.
73. Leick L, Fentz J, Biensa RS, Knudsen JG, Jeppesen J, et al. (2010) PGC-1a is
required for AICAR-induced expression of GLUT4 and mitochondrial proteins
in mouse skeletal muscle. Am J Physiol Endocrinol Metab 299: 456–465.
74. Dohm GL (2002) Exercise Effects on Muscle Insulin Signaling and Action:
Invited Review: Regulation of skeletal muscle GLUT-4 expression by exercise.
J Appl Physiol 93: 782–787.
75. McGee SL, Hargreaves M (2006) Exercise and skeletal muscle glucose
transporter 4 expression: Molecular mechanisms. Clin Exp Pharmacol Physiol
33: 395–399.
76. Suwa M, Egashira T, Nakano H, Sasaki H, Kumagai S (2006) Metformin
increases the PGC-1a protein and oxidative enzyme activities possibly via
AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol 101:
1685–1692.
77. Jager S, Handschin C, St-Pierre J, Spiegelman B (2007) AMP-activated protein
kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1a.
Proc Natl Acad Sci U S A 104: 12017–12022.
78. Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the
PGC-1 family of transcription coactivators. Cell Metab 1: 361–370.
79. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator-activated receptor-
g coactivator 1a (PGC-1a): Transcriptional coactivator and metabolic regulator.
Endocr Rev 24: 78–90.
80. Lee WJ, Kim M, Park H-S, Kim HS, Jeon MJ, et al. (2006) AMPK activation
increases fatty acid oxidation in skeletal muscle by activating PPARa and PGC-1
Biochem Biophys Res Commun 340: 291–295.
81. Suwa M, Nakano H, Kumagai S (2003) Effects of chronic AICAR treatment on
fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl
Physiol 95: 960–968.
82. Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T, et al. (2002) Effects of
low-intensity prolonged exercise on PGC-1 mRNA expression in rat
epitrochlearis muscle. Biochem Biophy Res Commun 296: 350–354.
83. LeMoine C, Craig P, Dhekney K, Kim J, McClelland G (2010) Temporal and
spatial patterns of gene expression in skeletal muscles in response to swim
training in adult zebrafish (Danio rerio). J Comp Physiol B 180: 151–160.
Metabolic Effects of AMPK on Fish Skeletal Muscle
PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e31219